Nationally Recruited Telehealth Group-Based Cognitive Behavioral Therapy for Insomnia in Patients with Primary Brain Tumors: A Randomized NIH ORBIT Phase IIc Study

Clicks: 16
ID: 327197
2026
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #98 of 144 articles by views in Neuro-Oncology Advances

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 144 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Abstract Background Sleep disturbance is common and undertreated in adults with primary brain tumors. Cognitive Behavioral Therapy for Insomnia (CBT-I) is the first-line, non-pharmacological treatment, yet its benefit in neuro-oncology has yet to be evaluated. This Phase IIc pilot assessed feasibility, acceptability, and meaningful effects of telehealth group-based CBT-I versus treatment as usual (TAU) in neuro-oncology. Methods Adults with primary brain tumors and chronic insomnia were randomized 1:1 to six weekly CBT-I sessions or TAU. Primary outcomes were feasibility of recruitment and longitudinal data collection, acceptability of CBT-I and study procedures, and changes in patient-reported insomnia severity, fatigue, and sleep quality. Results Recruitment met a priori feasibility benchmarks: Of the 84 patients screened, 96% were eligible, 86% consented, and 60 were randomized (CBT-I n=29; TAU n=31). Baseline data collection exceeded benchmarks, while longitudinal data collection was variable across outcomes. Patients deemed CBT-I as acceptable (86% intervention retention, 100% reporting improved sleep, 100% patient-recommendation), and provided high satisfaction ratings (>80%) across delivery, compensation, and most study procedures. On descriptive comparisons, CBT-I demonstrated greater preliminary acute improvements in insomnia severity (61% vs. 33%), fatigue (57% vs. 35%), and sleep quality (74% vs. 30%) than TAU, with medium-to-large effects (Cohen’s d = −0.69 to − 1.63 vs. d = −0.33 to − 0.73) observed on continuous measures. Conclusions Telehealth CBT-I is feasible, acceptable, and shows promising benefit signal in adults with primary brain tumors, particularly for improving insomnia. Future trials should optimize procedures for neurocognitive and accelerometer longitudinal data collection to support fully powered efficacy studies.
Reference Key
openalex_W7204845482 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Ashlee R. Loughan, Autumn Lanoye, Kelcie Willis, Amber Fox, Mary Bridgman, Nolan Wages, Youngdeok Kim, Alicia Zukas, Christopher Kleva
Are you one of these authors? Claim your profile
Journal Neuro-Oncology Advances
Year 2026
DOI
10.1093/noajnl/vdag226
URL
https://academic.oup.com/noa/advance-article-pdf/doi/10.1093/noajnl/vdag226/70881680/vdag226.pdf
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.